AprilWangArmstrongMDMPH

Dermatology • Los Angeles, CA

Chief of Dermatology at UCLA, Professor of Medicine

Join to view full profile

Dr. Armstrong is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Armstrong's full profile

Already have an account?

Office
911 Broxton Ave
3rd floor
Los Angeles, CA 90024
Phone+1 800-872-2273

Fax+1 323-442-5953

Education & Training

Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 2005 - 2008
Massachusetts General HospitalInternship, Internal Medicine, 2004 - 2005
Harvard Medical SchoolClass of 2004
Harvard School of Public HealthClinical Effectiveness Program
Harvard School of Public HealthM.P.H.

Certifications & Licensure

CA State Medical License 2008 - 2026
CO State Medical License 2013 - 2017
MA State Medical License 2004 - 2008
American Board of Dermatology Dermatology
National Board of Medical ExaminersDiplomate

Awards, Honors, & Recognition

Presidential Citation for Contributions to Psoriasis Research and Clinical Care American Academy of Dermatology, 2016
Young Dermatologist International Achievement Award International League of Dermatological Societies (ILDS)., 2015
Improving Healthcare Systems [SC14-1403-12419], Principal Investigator. Patient-Centered Outcomes Research Institute (PCORI), 2014
Faculty Mentor Award in Recognition of Excellence in Mentoring Students for the Medical Student Research Fellowship University of California Davis School of Medicine, 2010, 2012-2013
Recognition Award for Contributions to the Standards and Guidelines Committee Teledermatology Special Interest Group, American Telemedicine Association, 2012
First Prize in Pharmacology British Medical Association Medical Book Award, Associate Editor., 2012
Presidential Citation for Contributions to Teledermatology. American Academy of Dermatology, 2011
Patient-Directed Investigation Award Dermatology Foundation, Principal Investigator, 2010
Faculty Mentor Award in Recognition of Excellence in Mentoring NIH T32 Clinical Research Trainees University of California Davis School of Medicine., 2010
Academic Dermatology Leader Academic Dermatology Leadership Program (ADLP), American Academy of Dermatology., 2010
Editor’s Choice Award for Manuscript British Journal of Dermatology, 2010
Dermatology Foundation Career Development Award, Principal Investigator. 2009
NIAMS LRP Award NIAMS National Institutes of Health, Principal Investigator., 2009
Research Award to examine store-and-forward teledermatology technology California HealthCare Foundation, Principal Investigator., 2009
Research Award to examine access to dermatology using connected health technology Women’s Dermatologic Society, Principal Investigator, 2009
NIH K12 Mentored Career Development Program [National Institutes of Health RR 024144], Clinical and Translational Science Center University of California Davis Principal Investigator, 2009
Agency for Healthcare Quality and Research (AHRQ) K08 Mentored Clinical Scientist Research Career Development Award [PAR-09-085], Principal Investigator. 2009
First-Place Resident Research Award, "Text-Message Reminders Improve Medication Adherence to Sunscreen: A Randomized, Controlled Trial Using Electronic Monitoring," Department of Dermatology, Massachusetts General Hospital Clinical Research Conference., 2008
Resident Award (First Place) Teledermatology Special Interest Group, American Telemedicine Association, 2006, 2008
Connetics Clinical Research Fellowship for Improving Access to Dermatologic Care Center for Connected Health, Massachusetts General Hospital, Harvard Medical School, Principal Investigator, 2007
Recognition for Outstanding Poster 21st World Congress of Dermatology, Buenos Aires, Argentina., 2007
Dermatology Resident Scholarship to the 21st World Congress of Dermatology in Buenos Aires, Argentina American Academy of Dermatology, 2007
Dermatology Departmental Research Award, "A Secure, Fast, and Easily Accessible Dermatology Online Image Solution," Massachusetts General Hospital Clinical Research Conference., 2007
Information Technology Innovation Award: Academic Research grant to study medication adherence Information Systems Research Council, Partners HealthCare, Partners HealthCare, Co-Principal Investigator., 2007
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Fellow (FAAD) American Academy of Dermatology
Join now to see all

Clinical Trials

Comparison Of Video-based Versus Written Patient Education on Sunscreen Start of enrollment: 2009 Jan 01
Completed
Not Applicable
Comparison of Video-Based Versus Written Patient Education on Melanoma Start of enrollment: 2009 Jan 01
Completed
Not Applicable
Comparison Between Asynchronous Online Care Model With Usual In Office Care for the Management of Atopic Dermatitis Start of enrollment: 2009 Sep 01
Completed
Not Applicable
Use of Portable Technology in Patient Education of Shave/Punch Biopsies Start of enrollment: 2009 Jul 01
Completed
Not Applicable
Vascular Inflammation in Psoriasis Trial (The VIP Trial) Start of enrollment: 2012 Jul 01
Completed
Phase 4
Vascular Inflammation in Psoriasis - Extension Study Start of enrollment: 2013 Apr 01
Completed
Phase 4
Comparison Between Interactive Internet-based Education and Counseling for the Management of Acne With That of Internet-based Education Alone Start of enrollment: 2014 Jan 01
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Deucravacitinib in Japanese patients with plaque, generalized pustular, or erythrodermic psoriasis: Patient-reported outcomes in the POETYK PSO-4 study.
Yayoi Tada, April W Armstrong, Shinichi Imafuku, Yukari Okubo, Akimichi Morita
The Journal of Dermatology. 2024-12-06
1 citations
Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis: a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomiz...
Joseph F Merola, April Armstrong, Saakshi Khattri, So Yeon Paek, Byron Padilla
The Journal of Dermatological Treatment. 2024-12-01
Residual Lesional Gene Expression in Psoriasis Patients with Complete Skin Clearance Treated with Guselkumab or Adalimumab in VOYAGE 1 and 2.
Andrew Blauvelt, Kenneth B Gordon, Richard G Langley, Patrick J Branigan, Yanqing Chen
The Journal of Investigative Dermatology. 2024-12-01

Lectures

Controversies and Difficult Questions Concerning Biologic Therapeutics
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019
New Concepts and Emerging Therapies in Metabolic Disorders and Vascular Disease 2012
UC Davis Health System, Monterey, California - 10/6/2012

Other

Pathologic characteristics of melanoma
Armstrong AW, Mihm MC, Liu V
http://www.uptodate.com/contents/pathologic-characteristics-of-melanoma
UpToDate, Wolters Kluwer Health - 2013-01-27
Pathologic evaluation of regional lymph nodes in melanoma
Armstrong AW, Mihm MC, Liu V
http://www.uptodate.com/contents/pathologic-evaluation-of-regional-lymph-nodes-in-melanoma
UpToDate, Wolters Kluwer Health - 2012-08-09
Treatment selection for moderate to severe plaque psoriasis in special populations
Armstrong AW
http://www.uptodate.com/contents/treatment-selection-for-moderate-to-severe-plaque-psoriasis-in-spec
UpToDate, Wolters Kluwer Health - 2013-02-14

Press Mentions

FDA Approves First Once-Daily Oral Plaque Psoriasis DrugSeptember 18th, 2022
How to Spot the Difference Between Chronic and Acute InflammationAugust 30th, 2021

Committees

Chair, Sub-Committee On Teledermatology Outreach, American Telemedicine Association 2009 - 2011
Member, National Psoriasis Foundation Strategic Planning Committee

Research History

Researcher1. investigating epidemiology of comorbid conditions associated with inflammatory skin diseases such as psoriasis 2. evaluating the safe use of systemic medications for chronic inflammatory skin diseases 3. improving health care quality and effectiveness using tech-enabled healthcare delivery models